Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
2(17%)
Results Posted
14%(1 trials)

Phase Distribution

Ph early_phase_1
1
8%
Ph not_applicable
7
58%
Ph phase_1
2
17%
Ph phase_3
2
17%

Phase Distribution

3

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution12 total trials
Early Phase 1First-in-human
1(8.3%)
Phase 1Safety & dosage
2(16.7%)
Phase 3Large-scale testing
2(16.7%)
N/ANon-phased studies
7(58.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(7)
Other(3)

Detailed Status

Completed7
unknown3
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (8.3%)
Phase 12 (16.7%)
Phase 32 (16.7%)
N/A7 (58.3%)

Trials by Status

active_not_recruiting217%
unknown325%
completed758%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
12